The life science group Sartorius and Repligen Corporation today announced the launch of an integrated bioreactor system that incorporates Repligen XCell® ATF upstream intensification technology into Sartorius’ Biostat STR® bioreactor, simplifying intensified…
The war is changing the situation on the drug market: there is a certain shortage with imported medicines, and many of the Western pharmaceutical companies are still operating in the…